World Heart suffers filing setback with FDA
This article was originally published in Clinica
Executive Summary
The US FDA has refused to file World Heart's application to market its Novacor heart-assist device for long-term use, or destination therapy, in end-stage heart failure patients who are not candidates for heart transplantation.